COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by dougandtheslugs99on Mar 06, 2012 9:51pm

212 Views

Post# 19636367

RE: RE: RE: RE: RE: Just exactly what was said in

Smart move, Clint! With these drug related stocks,it's a cr*p shoot at best, 50/50. Look at what's happening with v.SSS. It was trading at .50 plus one morning then 24 hours later, it dropped by more than .30 and ever since then, which was almost 18 months ago, it has never recovered as it's now trading @ .045. Can you imagine those who were hanging on @ .50 and looking for the return of their life ended up losing their shirt.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide